DWG
ABBV icon

Darden Wealth Group’s AbbVie ABBV Stock Holding History

Darden Wealth Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Buy
4,782
+7
+0.1% +$1.51K 0.48% 49
2026
Q1 		$1.04M Hold
4,775
– – 0.53% 42
2025
Q4 		$1.09M Buy
4,775
+148
+3% +$33.7K 0.53% 48
2025
Q3 		$1.07M Hold
4,627
– – 0.56% 45
2025
Q2 		$859K Sell
4,627
-205
-4% -$38.1K 0.52% 50
2025
Q1 		$1.01M Hold
4,832
– – 0.78% 37
2024
Q4 		$859K Buy
4,832
+100
+2% +$18.4K 0.58% 43
2024
Q3 		$934K Buy
4,732
+155
+3% +$28.9K 0.67% 39
2024
Q2 		$785K Buy
4,577
+418
+10% +$69.2K 0.47% 41
2024
Q1 		$757K Buy
4,159
+2,168
+109% +$374K 0.59% 49
2023
Q4 		$309K Buy
+1,991
New +$290K 0.3% 72

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Darden Wealth Group's ABBV Position: Q2 2026 in Review

Darden Wealth Group increased its AbbVie (ABBV) stake by 0.15% in Q2 2026, buying an estimated $1.51K and bringing the position to 4,782 shares worth $1.2M. The position accounts for 0.48% of the portfolio, ranked #49.

Darden Wealth Group first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,222 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Darden Wealth Group held 4,782 shares of AbbVie worth $1.2M as of Q2 2026.
  • Darden Wealth Group bought 7 AbbVie shares in Q2 2026, an estimated $1.51K.
  • AbbVie made up 0.48% of Darden Wealth Group's portfolio in Q2 2026, its #49 holding.
  • Darden Wealth Group first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,222 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Darden Wealth Group's 13F filing for Q2 2026, filed 6 Aug 2026.